Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The papain inhibitor (SPI) of Streptomyces mobaraensis inhibits bacterial cysteine proteases and is an antagonist of bacterial growth.

Zindel S, Kaman WE, Fröls S, Pfeifer F, Peters A, Hays JP, Fuchsbauer HL.

Antimicrob Agents Chemother. 2013 Jul;57(7):3388-91. doi: 10.1128/AAC.00129-13.

2.

A novel transglutaminase substrate from Streptomyces mobaraensis inhibiting papain-like cysteine proteases.

Sarafeddinov A, Arif A, Peters A, Fuchsbauer HL.

J Microbiol Biotechnol. 2011 Jun;21(6):617-26.

3.

Isolation and characterization of a novel and potent inhibitor of Arg-gingipain from Streptomyces sp. strain FA-70.

Kadowaki T, Kitano S, Baba A, Takii R, Hashimoto M, Katunuma N, Yamamoto K.

Biol Chem. 2003 Jun;384(6):911-20.

PMID:
12887058
4.

Porphyromonas gingivalis cysteine proteinase inhibition by kappa-casein peptides.

Toh EC, Dashper SG, Huq NL, Attard TJ, O'Brien-Simpson NM, Chen YY, Cross KJ, Stanton DP, Paolini RA, Reynolds EC.

Antimicrob Agents Chemother. 2011 Mar;55(3):1155-61. doi: 10.1128/AAC.00466-10.

5.

Isolation, structure, and functional elucidation of a modified pentapeptide, cysteine protease inhibitor (CPI-2081) from Streptomyces species 2081 that exhibit inhibitory effect on cancer cell migration.

Singh JP, Tamang S, Rajamohanan PR, Jima NC, Chakraborty G, Kundu GC, Gaikwad SM, Khan MI.

J Med Chem. 2010 Jul 22;53(14):5121-8. doi: 10.1021/jm9014179.

PMID:
20552970
6.

Suppression of virulence of Porphyromonas gingivalis by potent inhibitors specific for gingipains.

Kadowaki T, Yamamoto K.

Curr Protein Pept Sci. 2003 Dec;4(6):451-8. Review.

PMID:
14683430
7.

Synergistic effect of ayurvedic pearl preparation on enhancing effectiveness of antibiotics.

Kulkarni M, Deopujari JY, Purohit HJ.

Indian J Exp Biol. 2002 Jul;40(7):831-4.

PMID:
12597554
8.

Acceleration of protease effect on Staphylococcus aureus biofilm dispersal.

Park JH, Lee JH, Cho MH, Herzberg M, Lee J.

FEMS Microbiol Lett. 2012 Oct;335(1):31-8. doi: 10.1111/j.1574-6968.2012.02635.x.

9.

Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.

Berggren K, Johansson B, Fex T, Kihlberg J, Björck L, Luthman K.

Bioorg Med Chem. 2009 May 1;17(9):3463-70. doi: 10.1016/j.bmc.2009.03.026.

PMID:
19362485
10.

Cryptostatin, a chagasin-family cysteine protease inhibitor of Cryptosporidium parvum.

Kang JM, Ju HL, Yu JR, Sohn WM, Na BK.

Parasitology. 2012 Jul;139(8):1029-37. doi: 10.1017/S0031182012000297.

PMID:
22444160
11.

Cys25-nitrosylation inactivates papain.

Venturini G, Fioravanti E, Colasanti M, Persichini T, Ascenzi P.

Biochem Mol Biol Int. 1998 Oct;46(2):425-8.

PMID:
9801811
12.

Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.

Irving JA, Pike RN, Dai W, Brömme D, Worrall DM, Silverman GA, Coetzer TH, Dennison C, Bottomley SP, Whisstock JC.

Biochemistry. 2002 Apr 16;41(15):4998-5004.

PMID:
11939796
13.

Antimicrobial protein from Streptomyces fulvissimus inhibitory to methicillin resistant Staphylococcus aureus.

Malik H, Sur B, Singhal N, Bihari V.

Indian J Exp Biol. 2008 Apr;46(4):254-7.

PMID:
18512335
14.

Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Dashper SG, Pan Y, Veith PD, Chen YY, Toh EC, Liu SW, Cross KJ, Reynolds EC.

Antimicrob Agents Chemother. 2012 Mar;56(3):1548-56. doi: 10.1128/AAC.05100-11.

15.

A novel sulfate-reducing bacteria detection method based on inhibition of cysteine protease activity.

Qi P, Zhang D, Wan Y.

Talanta. 2014 Nov;129:270-5. doi: 10.1016/j.talanta.2014.04.063.

PMID:
25127594
16.

Substrate specificity of Staphylococcus aureus cysteine proteases--Staphopains A, B and C.

Kalińska M, Kantyka T, Greenbaum DC, Larsen KS, Władyka B, Jabaiah A, Bogyo M, Daugherty PS, Wysocka M, Jaros M, Lesner A, Rolka K, Schaschke N, Stennicke H, Dubin A, Potempa J, Dubin G.

Biochimie. 2012 Feb;94(2):318-27. doi: 10.1016/j.biochi.2011.07.020.

PMID:
21802486
17.

Selective inhibition of Porphyromonas gingivalis growth by a factor Xa inhibitor, DX-9065a.

Matsushita K, Imamura T, Tancharoen S, Tatsuyama S, Tomikawa M, Travis J, Potempa J, Torii M, Maruyama I.

J Periodontal Res. 2006 Jun;41(3):171-6.

PMID:
16677284
18.

Antibacterial activity of Quercus ilex bark's extracts.

Berahou A, Auhmani A, Fdil N, Benharref A, Jana M, Gadhi CA.

J Ethnopharmacol. 2007 Jul 25;112(3):426-9.

PMID:
17513077
19.

Silkworm larvae as an animal model of bacterial infection pathogenic to humans.

Kaito C, Akimitsu N, Watanabe H, Sekimizu K.

Microb Pathog. 2002 Apr;32(4):183-90.

PMID:
12079408
20.

Growth inhibition of a human oral bacterium Porphyromonas gingivalis by rat cysteine proteinase inhibitor cystatin S.

Umemoto T, Naito Y, Li M, Suzuki I, Namikawa I.

Lett Appl Microbiol. 1996 Sep;23(3):151-3.

PMID:
8862019
Items per page

Supplemental Content

Support Center